Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CELF2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
mRNA | GS1-114I9.3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | CD300LD | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
mRNA | GOLGA7 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
mRNA | ATN1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
mRNA | KRTAP4-5 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
mRNA | APLP1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | GGA3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | ANKRD17 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
mRNA | DDX39B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |